Extended-Release Buprenorphine Found Well-Tolerated for Fentanyl Opioid Use Disorder

Eligible individuals with opioid use disorder using fentanyl received a single 4 mg dose of transmucosal buprenorphine followed by the extended-release buprenorphine 300 mg injection after approximately 1 hour.

Related Keywords

United States ,Berlin ,Germany ,New Jersey ,American ,Kimberly Boyles ,Indivior Inc ,American Journal ,Initiation Extension ,